CLASS II ONGOING Device recall · Reported 16 Feb 2022 · FDA Enforcement Report

Therakos Cellex Photopheresis Procedural Kit, Clxusa recalled

Mallinckrodt Pharmaceuticals Irel is recalling Therakos Cellex Photopheresis Procedural Kit, Clxusa, distributed nationwide in the US. The recall was initiated on 10 Dec 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesDunnage case consists of a random unknown lot, which may have been shipped in place of Kit lot K341
Quantity recalled3

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0567-2022
FDA event ID
89383
Recalling firm
Mallinckrodt Pharmaceuticals Irel, Dublin 15, N/A
Classification
Class II
Status
Ongoing
Recall initiated
10 Dec 2021
FDA classified
7 Feb 2022
Reported
16 Feb 2022
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Sterility

Timeline

10 Dec 2021Recall initiated by company
7 Feb 2022Classified by FDA+59 days
16 Feb 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

This recall was initiated to recover a Dunnage Case, which is a case of three (3) CLXUSA kits. This Dunnage Case was shipped on 02-Dec-2021. Dunnage is used during the sterilization process and is not intended for customer use.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA

Where it was distributed

US Nationwide distribution in the states of CA, FL, GA, MA, MI, NC, NJ, NY, OH, TN, TX, VA, WV.

Nationwide CaliforniaFloridaGeorgiaMassachusettsMichiganNorth CarolinaNew JerseyNew YorkOhioTennesseeTexasVirginiaWest Virginia

Questions about this recall

Why was it recalled?

This recall was initiated to recover a Dunnage Case, which is a case of three (3) CLXUSA kits. This Dunnage Case was shipped on 02-Dec-2021. Dunnage is used during the sterilization process and is not intended for customer use.

Which lots are affected?

Dunnage case consists of a random unknown lot, which may have been shipped in place of Kit lot K341

Where was it sold?

US Nationwide distribution in the states of CA, FL, GA, MA, MI, NC, NJ, NY, OH, TN, TX, VA, WV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Other Medical Devices recalls

All 13,778